MoneyWorks4Me

Advik Laboratories informs about disclosure

07 Apr 2020 Evaluate

Advik Laboratories has informed that it has enclosed disclosure of defaults on payment of interest/repayment of principal amount on loans from banks/ financial institutions for the quarter ended 31st March, 2020 in the prescribed format pursuant to SEBI circular no. SEBl/HO/CFD/CMDl/CIR/P/2019/140 dated 21st November, 2019.

The above information is a part of company’s filings submitted to BSE.

MPS Pharmaa Share Price

1.99 0.00 (0.00%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.40
Dr. Reddys Labs. 1180.50
Cipla 1431.85
Lupin 2225.00
Zydus Lifesciences 1117.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: